RxDoctor Payments Data

Thomas Williams, DO

Family Medicine · Milan, MONPI 1659479061

Payments from drug & device makers

$521in general payments, 2019–2025

Across 38 payments — averaging $13.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$276
  • Otsuka America Pharmaceutical, Inc.$38
  • Coloplast$36
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$30
  • Kowa Pharmaceuticals America, Inc.$29
  • Biohaven Pharmaceutical Holding Company Ltd.$28
  • plus $84 from 5 others

What the payments were for

  • Food & beverage$521100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$521 in reported general payments places this provider in the 50th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$4,112
Medicare patients
29
Services billed
50

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate24$44,037
EliquisApixaban54$39,464
OzempicSemaglutide28$29,497
XareltoRivaroxaban50$19,560
JardianceEmpagliflozin20$17,821
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl61$15,636
Victoza 3-PakLiraglutide20$15,367
LinzessLinaclotide25$12,545
FarxigaDapagliflozin Propanediol14$9,959
Tresiba Flextouch U-200Insulin Degludec16$8,495
Hysingla ErHydrocodone Bitartrate12$7,874
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen199$4,336
Fentanyl35$3,253
Ventolin HfaAlbuterol Sulfate46$2,720
Gabapentin118$2,354

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$23$39,46454 claims
AbbVieLinzess$276$12,54525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Milan

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →